SMDAM
ALNY icon

Sumitomo Mitsui DS Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.83M Buy
14,808
+1,851
+14% +$604K 0.04% 312
2025
Q1
$3.5M Buy
12,957
+1,346
+12% +$363K 0.04% 367
2024
Q4
$2.73M Buy
11,611
+30
+0.3% +$7.06K 0.03% 418
2024
Q3
$3.19M Sell
11,581
-533
-4% -$147K 0.03% 376
2024
Q2
$2.94M Buy
12,114
+2,619
+28% +$636K 0.03% 365
2024
Q1
$1.42M Sell
9,495
-28
-0.3% -$4.19K 0.02% 526
2023
Q4
$1.82M Hold
9,523
0.02% 474
2023
Q3
$1.69M Sell
9,523
-26
-0.3% -$4.61K 0.03% 441
2023
Q2
$1.81M Buy
9,549
+1,259
+15% +$239K 0.03% 428
2023
Q1
$1.66M Hold
8,290
0.03% 421
2022
Q4
$1.97M Hold
8,290
0.04% 355
2022
Q3
$1.66M Buy
8,290
+1,178
+17% +$236K 0.04% 371
2022
Q2
$1.04M Hold
7,112
0.02% 480
2022
Q1
$1.16M Sell
7,112
-34
-0.5% -$5.55K 0.02% 482
2021
Q4
$1.21M Buy
7,146
+1,197
+20% +$203K 0.03% 486
2021
Q3
$1.12M Sell
5,949
-80
-1% -$15.1K 0.03% 473
2021
Q2
$1.02M Sell
6,029
-28
-0.5% -$4.75K 0.02% 503
2021
Q1
$855K Buy
6,057
+2
+0% +$282 0.02% 526
2020
Q4
$786K Hold
6,055
0.02% 526
2020
Q3
$881K Hold
6,055
0.03% 448
2020
Q2
$896K Buy
6,055
+7
+0.1% +$1.04K 0.03% 421
2020
Q1
$658K Buy
6,048
+35
+0.6% +$3.81K 0.03% 436
2019
Q4
$692K Hold
6,013
0.02% 518
2019
Q3
$483K Buy
6,013
+1,803
+43% +$145K 0.02% 566
2019
Q2
$305K Sell
4,210
-15,833
-79% -$1.15M 0.01% 641
2019
Q1
$1.87M Sell
20,043
-1,462
-7% -$137K 0.03% 365
2018
Q4
$1.57M Buy
21,505
+2,120
+11% +$154K 0.03% 356
2018
Q3
$1.7M Sell
19,385
-47
-0.2% -$4.11K 0.03% 398
2018
Q2
$1.91M Buy
19,432
+13,877
+250% +$1.37M 0.03% 368
2018
Q1
$661K Sell
5,555
-63
-1% -$7.5K 0.01% 615
2017
Q4
$713K Buy
+5,618
New +$713K 0.01% 618
2016
Q4
Sell
-5,284
Closed -$358K 754
2016
Q3
$358K Hold
5,284
0.01% 681
2016
Q2
$293K Buy
5,284
+160
+3% +$8.87K 0.01% 673
2016
Q1
$321K Buy
5,124
+49
+1% +$3.07K 0.01% 665
2015
Q4
$477K Hold
5,075
0.02% 599
2015
Q3
$407K Sell
5,075
-300
-6% -$24.1K 0.01% 627
2015
Q2
$644K Buy
+5,375
New +$644K 0.02% 557